Back to search
FDAFDA · Food and drugs·Recall number D-0443-2025

Esomeprazole Magnesium for Delayed-Release Oral Suspension, 20 mg, 30-count single dose packets per carton, Rx Only, Manufactured by: Zydus Lifesciences Ltd. Ahmedabad, India, Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534, NDC 68382-848-94

Published May 28, 2025 · Recall initiated: May 13, 2025

Summary

FDA records drug Class II recall D-0443-2025, published May 28, 2025 and initiated May 13, 2025. Recalling firm: Zydus Pharmaceuticals (USA) Inc; Status: Ongoing; Reported quantity: 22,152 30 sachets/carton; Lot: Lot #:M402147, Exp 10/2025; M311637, Exp 07/2025; M402495, Exp 02/2026; M407997, Exp 05/2026; M502246, Exp11/2026. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Impurities/Degradation Specifications: Out-of-Specification test results obtained for any individual unknown degradation product during Related Compounds testing during long term stability.

What to do

Voluntary: Firm initiated · Letter

Get an email if ESOMEPRAZOLE MAGNESIUM has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
ESOMEPRAZOLE MAGNESIUM
Manufacturer
Zydus Pharmaceuticals (USA) Inc
Distributor
Nationwide -in the USA
Lot
Lot #:M402147, Exp 10/2025; M311637, Exp 07/2025; M402495, Exp 02/2026; M407997, Exp 05/2026; M502246, Exp11/2026.
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Esomeprazole Magnesium for Delayed-Release Oral Suspension, 20 mg, 30-count single dose packets per carton, Rx Only, Manufactured by: Zydus Lifesciences Ltd. Ahmedabad, India, Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534, NDC 68382-848-94 recalled?

Yes. FDA published recall D-0443-2025 on May 28, 2025. Reported hazard: Failed Impurities/Degradation Specifications: Out-of-Specification test results obtained for any individual unknown degradation product during Related Compounds testing during long term stability.

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: ESOMEPRAZOLE MAGNESIUM.